Two things are interesting about this announcement.
Firstly, we have confirmation that a phase 3 study is now being contemplated and secondly extended toxicology is being done. Neither of these events would be taking place if there were any doubt as to the future potential of 225 in the therapeutic marketplace.
- Forums
- ASX - By Stock
- BIT
- Ann: Presentation of HIV Data to CROI and New Patents
Ann: Presentation of HIV Data to CROI and New Patents, page-4
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M |
Open | High | Low | Value | Volume |
3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 720804 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 687471 | 0.030 |
2 | 988888 | 0.029 |
5 | 618000 | 0.028 |
3 | 567000 | 0.027 |
4 | 3124559 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 30000 | 1 |
0.035 | 299839 | 3 |
0.036 | 47708 | 1 |
0.037 | 537816 | 2 |
0.038 | 162500 | 1 |
Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |